
Aortic Valve Degeneration
🫀 Aortic Valve Degeneration in Horses 🫀 Aortic valve degeneration is a progressive condition in horses characterized by thickening, fibrosis, and dysfunction of the aortic valve leaflets, often leading to aortic regurgitation. This valvular insufficiency results in chronic volume overload of the left ventricle, eccentric hypertrophy, reduced cardiac output, and eventual heart failure. Horses may initially present with exercise intolerance and a diastolic murmur, progressing to arrhythmias and clinical signs of left-sided heart failure. Early diagnosis and appropriate management are essential to slow disease progression and mitigate complications such as atrial fibrillation or sudden death.
Comprehensive Information on Aortic Valve Degeneration and Associated Conditions in Horses for NAVLE Preparation
Definition
Aortic Valve Degeneration: A progressive condition characterized by the deterioration of the aortic valve leaflets, leading to valvular insufficiency or stenosis, which can result in significant hemodynamic disturbances in horses.
Etiology
Degenerative Changes: The primary cause of aortic valve degeneration in horses is age-related wear and tear, leading to thickening, fibrosis, and calcification of the valve leaflets.
Secondary Causes:
Infective Endocarditis: Bacterial colonization and subsequent inflammation can accelerate degenerative changes.
Congenital Malformations: Horses with congenital bicuspid aortic valves are predisposed to earlier degeneration.
Systemic Diseases: Conditions such as chronic kidney disease can promote calcification of the aortic valve.
Pathophysiology
Valve Insufficiency: Degeneration of the aortic valve leads to incompetence, where the valve fails to close properly, allowing blood to regurgitate from the aorta back into the left ventricle during diastole. This backflow increases the volume load on the left ventricle, leading to eccentric hypertrophy and, eventually, left-sided heart failure.
Valve Stenosis: In cases where the valve becomes stenotic due to calcification or fibrosis, there is an increased resistance to blood flow from the left ventricle into the aorta during systole. This results in increased left ventricular pressure, concentric hypertrophy, and a risk of ischemia and arrhythmias.
Hemodynamic Impact: The combination of increased volume load (in insufficiency) and pressure load (in stenosis) can severely compromise cardiac output and lead to decreased exercise tolerance, arrhythmias, and, in advanced cases, congestive heart failure.
Clinical Signs
Early Stages: Horses may be asymptomatic or show subtle signs of reduced exercise tolerance.
Progression:
Exercise Intolerance: Due to decreased cardiac output during exertion.
Syncope: Particularly in cases with severe stenosis due to transient reductions in cerebral perfusion.
Murmurs: A diastolic decrescendo murmur (in aortic insufficiency) or a systolic ejection murmur (in stenosis) may be auscultated over the left heart base.
Arrhythmias: Atrial fibrillation or ventricular arrhythmias can develop secondary to left ventricular hypertrophy and myocardial ischemia.
Advanced Stages:
Signs of Left-Sided Heart Failure: Pulmonary edema, coughing, and dyspnea may be present in severe cases.
Diagnosis
Auscultation: Detection of characteristic heart murmurs.
Echocardiography: The gold standard for diagnosing aortic valve degeneration, assessing valve morphology, regurgitant flow, and ventricular function.
Electrocardiography (ECG): Useful for detecting arrhythmias, particularly atrial fibrillation, which is common in horses with significant left atrial enlargement secondary to valve insufficiency.
Radiography: May show left ventricular enlargement or signs of congestive heart failure in advanced cases.
Cardiac Biomarkers: Elevated cardiac troponins may indicate myocardial strain or ischemia in severe cases.
Treatment
Medical Management:
Diuretics: Furosemide to manage pulmonary edema in heart failure.
Vasodilators: ACE inhibitors (e.g., enalapril) to reduce afterload and improve forward cardiac output.
Antiarrhythmics: Digoxin or quinidine for managing atrial fibrillation.
Surgical Management:
Valve Replacement: Rarely performed in horses due to the complexity and risk of surgery.
Balloon Valvuloplasty: May be considered in cases of stenosis, though it is rarely performed in equine practice.
Supportive Care:
Exercise Restriction: Horses with severe valvular disease should have their exercise limited to prevent exacerbation of clinical signs.
Nutritional Support: High-quality diets with attention to electrolyte balance can help manage horses with heart failure.
Prognosis
Mild Degeneration: Horses with mild aortic valve degeneration can often be managed medically and may continue to perform at a moderate level.
Severe Degeneration: Horses with severe valvular insufficiency or stenosis have a guarded prognosis, particularly if they develop heart failure or significant arrhythmias.
Complications
Congestive Heart Failure: Secondary to chronic volume overload in cases of aortic insufficiency.
Aortic Rupture: In severe cases of aortic valve degeneration with associated aortic root dilation, there is a risk of aortic rupture, which is often fatal.
Sudden Death: Due to ventricular arrhythmias or aortic rupture.
Atrial Fibrillation (AF)
AF in Horses with Aortic Valve Degeneration:
Pathophysiology: Atrial fibrillation is common in horses with left atrial enlargement due to chronic volume overload from aortic insufficiency. The irregular atrial rhythm exacerbates left ventricular filling issues and can lead to further reductions in cardiac output.
Diagnosis: Confirmed via ECG, showing absence of P waves and presence of irregular R-R intervals.
Treatment:
Rate Control: Digoxin is often used to control heart rate.
Rhythm Control: Quinidine sulfate for cardioversion, though care must be taken due to the risk of proarrhythmic effects in horses with underlying myocardial disease.
TVEC (Transvenous Electrical Cardioversion): May be considered for refractory cases.
Prognosis: Horses with concurrent aortic valve degeneration and AF have a worse prognosis due to the increased risk of heart failure and sudden death.
Reference:
Veterinary Clinics of North America: Equine Practice: Equine Acquired Valvular Disease

Do you have any feedback about the NAVLE Note?
We'd love to hear from you!
Feel free to send us a message
Don't forget to share with any friends who are also
preparing for the NAVLE Test.